Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase...

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Urokinase plasminogen activator (uPA) and its receptor (uPAR) are frequently overexpressed in various cancers, contributing to tumor progression and metastasis.
• Elevated expression of uPA and uPAR is observed in human breast cancer cell lines, suggesting a coordinated regulatory mechanism.

Purpose of the Study:

• To investigate the regulatory relationship between uPA and uPAR expression in breast cancer.
• To determine whether uPA expression is required for uPAR expression and vice versa.

Main Methods:

• Utilized antisense RNA technology to downregulate uPA and uPAR expression in MDA-MB-231 and BT-549 breast cancer cell lines.
• Employed monoclonal antibodies targeting uPA and uPAR to study their interaction.
• Investigated the role of soluble single-chain uPA (scuPA) and Fyn kinase in the uPA-uPAR signaling pathway.

Main Results:

• Antisense uPA RNA significantly reduced both uPA and uPAR expression, while antisense uPAR RNA only affected uPAR levels.
• Monoclonal antibodies disrupting the uPA-uPAR interaction, but not those inhibiting uPA protease activity, decreased uPAR expression.
• Re-introduction of soluble uPA restored uPAR expression in cells with downregulated uPA.

Conclusions:

• uPA dictates uPAR expression, and this regulation is mediated by the interaction between uPA and uPAR, transmitting signals for uPAR expression.
• Fyn, a Src family kinase, is implicated in the uPA-induced signaling pathway that regulates uPAR expression.
• These findings provide critical insights into the molecular mechanisms driving breast cancer progression and metastasis.